Illumina Body Map 2 (GSE30611)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ONECUT2 | hg38_v1_chr18_+_57435366_57435391 | 0.57 | 7.1e-04 | Click! |
ONECUT3 | hg38_v1_chr19_+_1753499_1753521 | -0.06 | 7.6e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr3_+_63443076 Show fit | 7.34 |
ENST00000295894.9
|
synaptoporin |
|
chr16_+_56191476 Show fit | 6.37 |
ENST00000262493.12
|
G protein subunit alpha o1 |
|
chr10_+_93757857 Show fit | 5.58 |
ENST00000478763.2
ENST00000371418.9 ENST00000630184.2 ENST00000630047.2 ENST00000637689.1 |
leucine rich glioma inactivated 1 |
|
chr7_-_100641507 Show fit | 5.01 |
ENST00000431692.5
ENST00000223051.8 |
transferrin receptor 2 |
|
chr1_+_159587817 Show fit | 5.00 |
ENST00000255040.3
|
amyloid P component, serum |
|
chr14_-_23578756 Show fit | 4.77 |
ENST00000397118.7
ENST00000356300.9 |
junctophilin 4 |
|
chr13_-_35855758 Show fit | 4.30 |
ENST00000615680.4
|
doublecortin like kinase 1 |
|
chr10_+_93757831 Show fit | 4.08 |
ENST00000629035.2
|
leucine rich glioma inactivated 1 |
|
chr16_+_56191536 Show fit | 3.81 |
ENST00000569295.6
|
G protein subunit alpha o1 |
|
chr13_-_35855627 Show fit | 3.55 |
ENST00000379893.5
|
doublecortin like kinase 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 15.0 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.0 | 9.7 | GO:0050806 | positive regulation of synaptic transmission(GO:0050806) |
1.8 | 8.9 | GO:2000473 | regulation of hematopoietic stem cell migration(GO:2000471) positive regulation of hematopoietic stem cell migration(GO:2000473) |
0.1 | 6.4 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.4 | 5.9 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
0.3 | 5.6 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.7 | 5.0 | GO:1903015 | regulation of exo-alpha-sialidase activity(GO:1903015) |
0.8 | 5.0 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.2 | 4.8 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.5 | 4.7 | GO:0021633 | optic nerve structural organization(GO:0021633) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 15.8 | GO:0045202 | synapse(GO:0045202) |
0.2 | 14.9 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 12.4 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.3 | 10.7 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.0 | 8.5 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 7.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.1 | 5.5 | GO:0030673 | axolemma(GO:0030673) |
0.3 | 5.0 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.3 | 4.8 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.2 | 4.7 | GO:0033010 | paranodal junction(GO:0033010) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 15.0 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.2 | 8.9 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 8.2 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.9 | 8.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.2 | 5.9 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.4 | 5.6 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.2 | 5.5 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
1.7 | 5.0 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.3 | 4.0 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 3.1 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 15.0 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 9.6 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.1 | 9.2 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 4.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 3.3 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 1.5 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 1.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 1.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.9 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.7 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 17.0 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.3 | 8.9 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 6.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 5.6 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 4.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 4.8 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 4.4 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 4.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 3.4 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.2 | 3.1 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |